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only linear models, at least for homeostat-
ic systems near their set points.
Mitchell et al.’s paper is impressive in
skipping from cell growth to nuclear local-
ization to gene transcription, without quite
tying all the pieces together, and it does
exhibit a lack of information about some
of the details, as noted above. Neverthe-
less, they have elegantly shown how the
outside-in, cybernetic approach can be
combined with the inside-out molecular
approach to offer a powerful way to inter-
pret and re-engineer networks, without
floundering in the molecular details. Syn-
thetic biologists, including those in the
Lim lab (Wu et al., 2015), have already
begun re-engineering T cell receptors,
with tantalizing implications for cell-based
immunotherapy. It is important to under-
stand the fragilities of these systems and
to ensure that they are not encountered
in the patients on whom such therapies
will be tested. Perhaps cybernetics is yet
to have its greatest impact on biology.
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Pancreatic b cells synthesize and secrete insulin to increase anabolic metabolism in an organism, and
insulin synthesis has long been suspected to inhibit b cell replication. Recently in Cell Metabolism, Szabat
et al. (2015) present evidence that deletion of Insulin genes alleviates ER stress and promotes mature
b cell replication.The b cells in the islets of Langerhans are
long-lived cells that secrete the important
endocrine hormone insulin. Insulin plays
a pivotal role in maintaining metabolic
homeostasis, and its action affects major
aspects of cellular metabolism, such as
glucose absorption and synthesis, lipid
synthesis and breakdown, and cellular
proliferation and differentiation. Insulin
secretion must be tightly regulated to co-
ordinate cellular metabolism with nutrient
availability. Dysregulation of insulin syn-
thesis and secretion leads to diabetes,
characterized by abnormally high levels
of glucose in the blood. Despite the
abundant knowledge regarding insulin’s
biological effects, little is known about
the regulation of insulin synthesis and its4 Developmental Cell 36, January 11, 2016 ªeffect on b cell health. Although charac-
terizing b cells without insulin production
poses both theoretical and technical
challenges, a pioneering attempt to
generate a mouse model with compound
insulin gene knockout (Ins1/2 KO
mouse) showed that insulin production is
dispensable for both embryogenesis and
islet organogenesis (Duvillie´ et al., 1997).
Preliminary observations from this study
also suggested that insulin synthesis
negatively regulates b cell proliferation.
However, whether the hypothesis holds
true for mature b cells remained largely
un-tested for almost two decades. Re-
porting recently in Cell Metabolism, Sza-
bat et al. (2015) present a breakthrough
study showing that normal transcription2016 Elsevier Inc.and translation of insulin suppresses
b cell proliferation and induces endo-
plasmic reticulum (ER) stress-sensing
pathways, i.e., the unfolded protein
response (UPR), and that relief from ER
stress promotes cell proliferation through
the AKT-Cyclin D1 axis.
Pancreatic b cells are notoriously resis-
tant to cellular replication, and it has
been longpostulated that the burden of in-
sulin synthesis inhibits cell cycle re-entry.
Although there is evidence supporting
the notion that cellular proliferation ham-
pers b cell differentiation (Scharfmann
et al., 2014), it is unknown if reducing insu-
lin synthesis can directly promote b cell
replication. The inability to test the hypoth-
esis in vivo ismainly due to insulin’s pivotal
Figure 1. Physiological Proinsulin Synthesis Inhibits b Cell Replication through the UPR
Results obtained from the Ins1 KO/Ins2 floxed mouse model by Szabat et al. (2015) suggest that under
physiological conditions, a portion of newly synthesized proinsulin misfolds and binds to BiP, causing sub-
threshold, chronic ER stress characterized by constitutive activation of the PERK/eIF2a-P pathway (left
panel). Reducing proinsulin synthesis by deleting the floxed alleles of Ins2 genes decreases proinsulin
misfolding, alleviates ER stress, reduces PERK/eIF2a-P signaling, and decreases Atf4/ChopmRNA levels
in primary b cells. At the same time, multiple b cell replication markers are induced together with a sig-
nificant increase in AKT phosphorylation and CYCLIN D1 and a decrease in the AKT inhibitory TRIB3
protein from the nucleus (right panel).
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insulin expression inevitably leads to hy-
perglycemia,which stimulatesmyriadbio-
logical effects. By applying multi-faceted
systems biology tools on a sophisticated
genetic model—Ins2 alleles floxed mice
with deleted Ins1 alleles—Szabat et al.
(2015) provide the first evidence support-
ing the latter idea. Their study focused on
a time point at 6 days post Ins2 gene dele-
tion, when there is 50% loss of the Ins2
mRNA and INS2 protein in b cells but the
remaining insulin reserve is sufficient to
prevent hyperglycemia. Strikingly, loss of
Ins2 mRNA and protein did not change b
cell identity, as represented by key b cell
differentiation transcription factors such
as Pdx1, MafA, Nkx6.1, and Ngn3, nor
did it alter glucose and KCl responsive-
ness, as assayed by insulin release and
intracellular Ca2+ homeostasis. The early
transcriptome and proteome changes
upon insulin deletion included the
UPR pathway and, more specifically,
reduced signaling through the PERK/
eIF2a-P/ATF4 branch. Downregulation ofUPR effector molecules was followed by
aprompt upregulation of theAKT-CYCLIN
D1 axis, which promotes cellular prolifera-
tion. Collectively, the observations sup-
port the notion that establishment of b
cell identity precedes insulin transcription,
and chronic ER stress from insulin syn-
thesis restrains cell-cycle progression.
Conversely, as attenuating insulin synthe-
sis alleviates ER stress, it becomes an
attractive strategy to direct mature b cells
toward replication.
The UPR is signaled through activation
of the protein kinases PERK and IRE1a
by auto-phosphorylation and through
proteolytic liberation of the membrane-
anchored transcription factor ATF6a
(Figure 1). Under ER homeostasis, the
UPR sensors aremaintained in an inactive
state through interaction with the protein
chaperone BiP (also known as GRP78)
located inside the ER lumen. When ER
stress develops, unfolded proteins accu-
mulate in the ER lumen and titrate away
BiP protein, thereby releasing PERK,
IRE1a, and ATF6a for activation andDevelopmental Cesignaling. Szabat et al. (2015) demon-
strated that in mature b cells, Ins2 mRNA
quantitatively accounts for ‘‘more mRNA
than the next 500 most highly expressed
transcripts combined.’’ It then comes as
no surprise that insulin translation and
folding under physiological conditions
is sufficient to incur low-grade, chronic
PERK activation. Our current knowledge
of the PERK/eIF2a-P/ATF4 pathway pre-
dicts that activated PERK leads to pro-
found yet transient inhibition of proinsu-
lin synthesis by phosphorylating serine
51 residue of the alpha subunit of the
eukaryotic translation initiation factor 2
(eIF2a-P), and mutations in both PERK
and eIF2a are sufficient to trigger b cell
failure due to loss of translation control
(Dele´pine et al., 2000; Scheuner et al.,
2005; Back et al., 2009). Paradoxically,
eIF2a-P is required for the translation
of a growing list of mRNAs, including
the well-characterized molecules Atf4,
Chop, Gadd34, and Atf5. Upon eIF2a-P,
Atf4 mRNA is selectively translated to
activate the amino acid response element
(AARE) in target genes, including the
Chop gene. Contrary to the legacy belief
that CHOP mediates cell death through
transcriptional upregulation of a specific
apoptotic factor, a genome-wide search
for CHOP-bound promoter sequences re-
vealed that CHOP exerts pro-apoptotic
response in conjunction with ATF4 by
placing an extra burden on protein syn-
thesis (Han et al., 2013). This effect is
partially mediated through revving up the
cellular mRNA translational machinery,
such as aminoacyl-tRNA synthetases,
ribosomal subunits, translation initiation
factors, and amino acid transporters.
Consistent with this, the most significant
gene cluster affected by Ins1/2 deletion
was mapped to the same mRNA and pro-
tein species, which was further corrobo-
rated by reduction in Atf4, Chop, and
Xbp1s mRNA and a decreased amount
of eIF2a-P. In addition, Szabat et al.
(2015) reported a moderate reduction in
ER and Golgi compartment proteins that
are responsible for proinsulin synthesis,
folding, trafficking, processing, and
granule sorting. On the other hand, the
degree of ER stress in b cells under
physiological conditions is apparently
insufficient to trigger a death response,
although the constant chronic ER stress
conditions predict the b cell’s vulnerability
in response to additional levels of stress,ll 36, January 11, 2016 ª2016 Elsevier Inc. 5
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diabetes or exacerbated workload to
synthesize an overwhelming amount of
insulin in type II diabetes. The finding
that proinsulin misfolding precedes other
detectable b cell abnormalities after
high-fat diet feeding, including glucose
intolerance, further substantiates the
notion that ER stress and proinsulin mis-
folding together initiate b cell failure
(Scheuner et al., 2005). In addition, unreg-
ulated proinsulin synthesis provoked all
the hallmarks of b cell failure in human
type II diabetes, indicating that excessive
proinsulin synthesis and misfolding may
be an initiating event in type II diabetes
(Back et al., 2009). Conversely, it was
demonstrated that removing the Chop
gene in b cells partially alleviates cell
stress and increases proliferation (Song
et al., 2008), consistent with the observa-
tions reported by Szabat et al. (2015).
Further advancing our knowledge, the
work from Szabat et al. (2015) made the
pioneering effort to investigate the mech-
anism responsible for increased prolif-
eration in Ins1/2 double-KO b cells and
suggests that de-activation of TRIB3
in the AKT/CYCLIN D1 pathway in turn
promotes cellular proliferation (Du et al.,
2003), while the role of the MEK/ERK
pathway remains to be defined. Finally,
based on recent observations (Hassler
et al., 2015), it would be important to
fully characterize proinsulin processing
and granule production upon deletion of
the Ins genes.6 Developmental Cell 36, January 11, 2016 ªTo summarize, these findings provide
valuable insight into the role of ER stress
in maintaining the striking inverse relation-
ship between growth and differentiation
observed in b cells. However, the inherent
inability of Ins1/2 double-KO b cells to re-
synthesize insulin both during and after
cell-cycle completion precludes evalua-
tion of long-term effects on murine b cell
mass. It will be especially intriguing to
translate these findings to human b cells
that exhibit a significantly lowerbasal repli-
cation rate than their murine counterparts.
Nevertheless, considering the complexity
of in vivo signaling networks regulating
b cell replication, the genetic design by
Johnson’sgroup isuniquelyclean, yielding
convincing results that converge with our
knowledge of the UPR pathways.
It will also be of interest to determine
the response from the other two branches
of the UPR pathways, ATF6a and IRE1a,
which were not extensively characterized
by the authors. Recent reports implicate
their involvement in normal b cell physi-
ology (Hassler et al., 2015) and suggest
that IRE1a-XBP1s signaling is responsible
for maintaining healthy ER/Golgi organ-
elles that allow b cells to properly respond
to dramatic changes in blood glucose,
while the ATF6a pathway may be
dispensable. Finally, it will be important
to determine whether high protein secre-
tion in differentiated cells is generally
incompatible with cell division. The
answer to this question may yield unique
insights to treating numerous diseases.2016 Elsevier Inc.REFERENCES
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